- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04554654
Progesterone Levels and Endometrial Compaction in Frozen-Thawed Embryo Transfer Cycles
January 8, 2021 updated by: Cem Demirel
The Correlation of Serum Progesterone Levels With the Degree of Endometrial Compaction on the Day of Frozen Embryo Transfer
This study is intended to determine whether there is a correlation between endometrial compaction and serum progesterone levels on the day of frozen embryo transfers by using transvaginal sonography for the endometrial assessment.
Study Overview
Status
Unknown
Intervention / Treatment
Detailed Description
This study is planned to be conducted by prospectively evaluating approximately 200 frozen embryo transfers within 6 months in a single center.
Patients planned to be included in the study are started estrodiol 6 mg / day on day2-3 of mensturation.
12 days after the start of estrogen, patients who have endometrial thickness over 7 mm are then started vaginal progesterone supplementation as per routine practice and are eventually proceeded to embryo transfer either on day 4 or 6 of progesterone supplementation.
In this study investigators are intended to measure endometrial thickness transvaginally on the day of embryo transfer to accurately determine the presence of endometrial compaction, assess serum progesterone levels, evaluate any possible correlations between endometrial compaction, serum progesterone levels and pregnancy rates.
Study Type
Observational
Enrollment (Anticipated)
200
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
İstanbul, Turkey, 34758
- Recruiting
- Ataşehir Memorial Hospital IVF Department
-
Contact:
- Fırat Tulek, MD
- Phone Number: +905306084874
- Email: firattulek@yahoo.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 40 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Women underwent frozen embryo transfer
Description
Inclusion Criteria:
- Woman aged 20-40 years
- Hormonal(estrogen and progesterone) frozen- thawed embryo transfer cycles
- Having available blastocyst(s) cryopreserved by vitrification method.
Exclusion Criteria:
- Recurrent implantation failure
- Recurrent pregnancy loss
- Presence of uterine pathology
- Requirement for fresh embryo(s);
- Presence of any clinically relevant systemic disease contraindicated for assisted reproduction or pregnancy
- Allergy history for relevant drugs
- Body mass index of <18 or >38 kg/m2 at screening
- Current breastfeeding or pregnancy
- Refusal or inability to comply with the requirements of the protocol for any reason, including scheduled clinic visits and laboratory tests
- Natural or modified natural cycles
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
frozen embryo transfer cycles
patients undergoing frozen embryo transfer with artificial hormone replacement
|
transvaginal ultrasound performed on day of the start of progesterone supplementation and on the day of frozen embryo transfer; serum progesterone level measurement on day of frozen embryo transfer
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Ongoing pregnancy rates
Time Frame: 12 weeks after the last menstrual period of the patient
|
Presence of at least one live fetus at the end of the 12th gestational week in patients with endometrial compaction compared to patients without endometrial compaction after frozen embryo transfer
|
12 weeks after the last menstrual period of the patient
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Implantation rate
Time Frame: 5 weeks after the last menstrual period of the patient
|
Percentage of gestational sacs compared to the number of embryos transferred
|
5 weeks after the last menstrual period of the patient
|
Clinical pregnancy rate
Time Frame: 6-7 weeks after the last menstrual period of the patient
|
Presence of an intrauterine gestational sac with fetal heart beat at 7th week of gestation
|
6-7 weeks after the last menstrual period of the patient
|
The Correlation of Serum Progesterone Levels With the Degree of Endometrial Compaction on the Day of Frozen Embryo Transfer
Time Frame: On the day of frozen embryo transfer
|
endometrium compacted (became thinner) after the administration of progesterone
|
On the day of frozen embryo transfer
|
Clinical miscarriage rate
Time Frame: after 5th gestational week
|
pregnancy loss after ultrasonographic detection of an intrauterine gestational sac
|
after 5th gestational week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
June 15, 2020
Primary Completion (ANTICIPATED)
January 15, 2021
Study Completion (ANTICIPATED)
February 15, 2021
Study Registration Dates
First Submitted
September 4, 2020
First Submitted That Met QC Criteria
September 13, 2020
First Posted (ACTUAL)
September 18, 2020
Study Record Updates
Last Update Posted (ACTUAL)
January 11, 2021
Last Update Submitted That Met QC Criteria
January 8, 2021
Last Verified
January 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 9995381
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infertility, Female
-
Esraa Gamal AhmedAin Shams Maternity HospitalUnknownUnexplained Female Infertility
-
Pacific Fertility CenterTerminatedPrimary Female Infertility | Secondary Female Infertility
-
Assuta Hospital SystemsMaccabi Healthcare Services, IsraelCompletedInfertility, Female Infertility, Male InfertilityIsrael
-
Newlife Fertility CentreRecruitingInfertility | Infertility,Female | Infertility Unexplained | Infertility of Uterine Origin | Infertility; Female, NonimplantationCanada
-
Cairo UniversityCompleted
-
Navy General Hospital, BeijingUnknownFemale Infertility Due to Nonimplantation of OvumChina
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedPregnancy | Male Infertility | Female InfertilityNetherlands
-
Woman's Health University Hospital, EgyptCompletedFemale Infertility Due to Diminished Ovarian ReserveEgypt
-
Woman's Health University Hospital, EgyptCompleted
-
The University of Hong KongCompletedFemale Infertility Due to Diminished Ovarian ReserveHong Kong
Clinical Trials on transvaginal ultrasound,
-
University Hospital MuensterCompleted
-
Washington University School of MedicineNational Cancer Institute (NCI)Completed
-
University of AarhusCompleted
-
Aljazeera HospitalKasr El Aini HospitalUnknown
-
ART Fertility Clinics LLCCompletedEndometrial DiseasesUnited Arab Emirates
-
Intermountain Women and Children's ResearchUnknownCervical InsufficiencyUnited States
-
Semmelweis UniversityCharles University, Czech Republic; Jagiellonian University; St John of God Hospital...Not yet recruitingEndometriosis | Radiculopathy | Nerve Sheath TumorHungary
-
ChaingMai UniversityWithdrawnPreterm Delivery Within 7 Day After AdmissionThailand
-
Dina Mohamed Refaat DakhlyCompleted
-
Hadassah Medical OrganizationUnknownIn Vitro FertilizationIsrael